Home

Katherine Stueland, CEO: GeneDx Holdings WGS Sell · Filed 25/03/17

Trade details

Type
Insider sale
Amount
$1,021,160.89
Shares · price
10,559 sh · $96.71 a share
Held after
14,865 sh
Trade date
25/03/17
Filed
25/03/17
Days to filing
0 days

Sold 41.5% of holdings

Share of holding sold
41.5%

GeneDx Holdings trades, last 26 weeks

What else happened in GeneDx Holdings around then

Filed or reported within 30 days of the trade day · 25/02/15~25/04/16

Katherine Stueland's recent trades

  • Katherine Stueland

    Planned saleGeneDx Holdings

    $1.2M

    Filed 09/01

  • Katherine Stueland

    SellGeneDx Holdings

    $360.8K

    Filed 06/18

  • Katherine Stueland

    SellGeneDx Holdings

    $149.4K

    Filed 06/18

  • Katherine Stueland

    SellGeneDx Holdings

    $127.9K

    Filed 06/18

  • Katherine Stueland

    SellGeneDx Holdings

    $195.7K

    Filed 06/11

Katherine Stueland, CEO — sold $1M of GeneDx Holdings WGS · 41.5% of holdings | Whalegun